Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases
Authors:
- Chul ParkCPChul Park
- Yoomi YeoYYYoomi Yeo
- Sung Woo ParkSPSung Woo Park
- on Behalf of the Korean Interstitial Lung Disease Study GroupOGon Behalf of the Korean Interstitial Lung Disease Study Group
Open Access
- 1 October 2025
- journal article
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 88 (4) , 654-672
Abstract
Interstitial lung disease (ILD) comprises a heterogeneous group of disorders characterized by interstitial compartment proliferation, inflammatory infiltration, and potential fibrosis with abnormal collagen deposition. Diagnosis requires a multidisciplinary consensus integrating clinical, radiological, and pathological findings. Idiopathic interstitial pneumonia (IIP) includes idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia, desquamative interstitial pneumonia, acute interstitial pneumonia, and respiratory bronchiolitis-ILD, each exhibiting distinct prognostic and therapeutic implications. Some non-IPF ILDs progress despite standard treatment, classified as progressive fibrosing-ILD or progressive pulmonary fibrosis (PPF), diagnosed by worsening symptoms, physiological decline, and radiological progression. Nintedanib is conditionally recommended for refractory PPF cases. Combined pulmonary fibrosis and emphysema is characterized by upper-lobe predominant emphysema and lower-lobe fibrosis, frequently complicated by pulmonary hypertension and lung cancer. Interstitial lung abnormality, observed in both smokers and the general population, is associated with increased mortality and disease risk, warranting further research. Despite advancements, refinement in classification, diagnostic criteria, and therapeutic strategies remains crucial for improving patient outcomes.Keywords
Funding Information
- National Research Foundation of Korea (RS-2023-00274884)
- Ministry of Science and ICT
This publication has 71 references indexed in Scilit:
- Interstitial Lung Abnormalities and Reduced Exercise CapacityAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypesEuropean Respiratory Journal, 2012
- Significance of connective tissue disease features in idiopathic interstitial pneumoniaEuropean Respiratory Journal, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The radiological patterns of interstitial change at an early phase: Over a 4-year follow-upRespiratory Medicine, 2010
- Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndromeEuropean Respiratory Journal, 2009
- Combined pulmonary fibrosis and emphysema: a distinct underrecognised entityEuropean Respiratory Journal, 2005
- Role of Thoracic Surgeons in the Diagnosis of Idiopathic Interstitial Lung DiseaseThe Annals of Thoracic Surgery, 2005
- Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in FinlandThorax, 2002
- A Mutation in the Surfactant Protein C Gene Associated with Familial Interstitial Lung DiseaseNew England Journal of Medicine, 2001